Kalyra Pharmaceuticals, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2012-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://kalyrapharma.com
A Single and Multiple Ascending Dose Study in Healthy Subjects to Assess the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of KP-1199
Phase 1
Terminated
- Conditions
- Analgesia
- Interventions
- First Posted Date
- 2019-03-19
- Last Posted Date
- 2021-09-16
- Lead Sponsor
- Kalyra Pharmaceuticals, Inc.
- Target Recruit Count
- 26
- Registration Number
- NCT03880487
- Locations
- 🇺🇸
PRA Health Sciences, Salt Lake City, Utah, United States
© Copyright 2025. All Rights Reserved by MedPath